It was found that the specification limit for contamination (Impurity B) in batch 49N013A was exceeded, which means failure to meet established quality requirements and represents a real and probable risk to patients’ health. Potential effects: adverse reactions, treatment complications, possible deterioration of health.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Symibace 5 mg from batch 49N013A, check the batch number on the packaging, and return any packages held to a pharmacy; if the medicine from this batch has been taken, contact a doctor.
The Chief Pharmaceutical Inspector withdrew batch 49N013A of Symibace 5 mg from the market throughout the country and prohibited its placing on the market, granting the decision immediate enforceabili...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related